Concepts (286)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Military Personnel | 14 | 2024 | 85 | 6.740 |
Why?
|
Petroleum Pollution | 7 | 2021 | 11 | 3.940 |
Why?
|
Occupational Exposure | 17 | 2017 | 80 | 3.300 |
Why?
|
Environmental Pollutants | 6 | 2024 | 51 | 3.280 |
Why?
|
Thyroid Neoplasms | 5 | 2024 | 408 | 2.120 |
Why?
|
Polychlorinated Biphenyls | 4 | 2024 | 7 | 2.020 |
Why?
|
Petroleum | 5 | 2021 | 13 | 2.010 |
Why?
|
Emergency Responders | 3 | 2018 | 6 | 1.800 |
Why?
|
Water Pollutants, Chemical | 4 | 2021 | 135 | 1.560 |
Why?
|
DNA Methylation | 5 | 2016 | 628 | 1.530 |
Why?
|
Early Detection of Cancer | 3 | 2023 | 392 | 1.270 |
Why?
|
Occupational Diseases | 4 | 2017 | 55 | 1.200 |
Why?
|
Internal Medicine | 3 | 2023 | 347 | 1.190 |
Why?
|
Internship and Residency | 3 | 2022 | 1004 | 1.180 |
Why?
|
Carcinoma, Papillary | 2 | 2018 | 158 | 1.110 |
Why?
|
Ships | 3 | 2017 | 5 | 1.040 |
Why?
|
Hydrocarbons, Chlorinated | 2 | 2019 | 4 | 1.000 |
Why?
|
Health Equity | 2 | 2023 | 77 | 0.990 |
Why?
|
Curriculum | 5 | 2023 | 539 | 0.980 |
Why?
|
Pesticides | 7 | 2016 | 29 | 0.980 |
Why?
|
Case-Control Studies | 13 | 2024 | 1804 | 0.960 |
Why?
|
Endocrine Disruptors | 1 | 2024 | 27 | 0.950 |
Why?
|
Agricultural Workers' Diseases | 9 | 2015 | 18 | 0.930 |
Why?
|
Students, Health Occupations | 1 | 2023 | 5 | 0.920 |
Why?
|
Sexual Health | 1 | 2022 | 14 | 0.880 |
Why?
|
Long Interspersed Nucleotide Elements | 2 | 2012 | 12 | 0.830 |
Why?
|
Humans | 64 | 2024 | 86601 | 0.830 |
Why?
|
Vaginal Smears | 1 | 2021 | 68 | 0.820 |
Why?
|
Respiratory Tract Diseases | 3 | 2018 | 45 | 0.800 |
Why?
|
Sexually Transmitted Diseases | 1 | 2022 | 91 | 0.800 |
Why?
|
Students, Medical | 2 | 2023 | 384 | 0.790 |
Why?
|
Adult | 35 | 2024 | 25640 | 0.790 |
Why?
|
Insecticides | 5 | 2010 | 27 | 0.760 |
Why?
|
Female | 41 | 2024 | 44507 | 0.750 |
Why?
|
Halogenated Diphenyl Ethers | 1 | 2020 | 3 | 0.750 |
Why?
|
Polybrominated Biphenyls | 1 | 2020 | 5 | 0.740 |
Why?
|
Dichlorodiphenyl Dichloroethylene | 1 | 2019 | 6 | 0.740 |
Why?
|
Herbicides | 7 | 2015 | 35 | 0.730 |
Why?
|
Education, Medical | 1 | 2023 | 233 | 0.730 |
Why?
|
Middle Aged | 36 | 2024 | 25017 | 0.720 |
Why?
|
Breast Density | 1 | 2019 | 31 | 0.720 |
Why?
|
Stomach Neoplasms | 3 | 2011 | 266 | 0.710 |
Why?
|
Breast Neoplasms | 6 | 2023 | 2887 | 0.690 |
Why?
|
Cross-Sectional Studies | 6 | 2021 | 1621 | 0.680 |
Why?
|
Interleukin-16 | 1 | 2018 | 7 | 0.680 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2021 | 275 | 0.670 |
Why?
|
Papillomavirus Infections | 1 | 2021 | 239 | 0.660 |
Why?
|
DNA | 4 | 2016 | 1294 | 0.650 |
Why?
|
Nervous System Diseases | 1 | 2019 | 151 | 0.650 |
Why?
|
Mortality | 3 | 2009 | 149 | 0.650 |
Why?
|
Interleukin-15 | 1 | 2018 | 72 | 0.640 |
Why?
|
Adenocarcinoma | 2 | 2019 | 1169 | 0.640 |
Why?
|
Hot Temperature | 1 | 2018 | 206 | 0.640 |
Why?
|
Environmental Exposure | 5 | 2021 | 296 | 0.620 |
Why?
|
Male | 37 | 2024 | 40956 | 0.610 |
Why?
|
Prospective Studies | 18 | 2021 | 4210 | 0.610 |
Why?
|
Construction Industry | 1 | 2017 | 1 | 0.610 |
Why?
|
Respiratory Tract Neoplasms | 1 | 2017 | 2 | 0.610 |
Why?
|
Brain Neoplasms | 2 | 2024 | 763 | 0.600 |
Why?
|
Farmers | 1 | 2016 | 5 | 0.600 |
Why?
|
Air Pollutants, Occupational | 1 | 2016 | 6 | 0.600 |
Why?
|
Ostomy | 1 | 2017 | 15 | 0.600 |
Why?
|
North Carolina | 15 | 2016 | 50 | 0.590 |
Why?
|
Huntington Disease | 1 | 2017 | 37 | 0.590 |
Why?
|
Neoplasms | 14 | 2015 | 2897 | 0.580 |
Why?
|
Carcinogens | 5 | 2015 | 108 | 0.580 |
Why?
|
Occupational Health | 1 | 2016 | 32 | 0.580 |
Why?
|
Iowa | 14 | 2016 | 35 | 0.580 |
Why?
|
Guidelines as Topic | 1 | 2017 | 162 | 0.580 |
Why?
|
Glioma | 1 | 2018 | 285 | 0.560 |
Why?
|
Patient Participation | 1 | 2018 | 216 | 0.560 |
Why?
|
Thyrotropin | 1 | 2017 | 280 | 0.560 |
Why?
|
Colonoscopy | 1 | 2017 | 264 | 0.540 |
Why?
|
Gulf of Mexico | 3 | 2021 | 5 | 0.540 |
Why?
|
Education, Medical, Graduate | 2 | 2023 | 369 | 0.530 |
Why?
|
Health Behavior | 1 | 2017 | 183 | 0.530 |
Why?
|
Promoter Regions, Genetic | 3 | 2016 | 937 | 0.510 |
Why?
|
Cyclonic Storms | 1 | 2014 | 4 | 0.500 |
Why?
|
Cognitive Dysfunction | 1 | 2017 | 132 | 0.500 |
Why?
|
Practice Guidelines as Topic | 1 | 2021 | 1034 | 0.500 |
Why?
|
Cohort Studies | 13 | 2023 | 2767 | 0.480 |
Why?
|
Receptors, Progesterone | 2 | 2005 | 167 | 0.480 |
Why?
|
Prostatic Neoplasms | 4 | 2019 | 1720 | 0.470 |
Why?
|
Mesothelioma | 1 | 2017 | 311 | 0.470 |
Why?
|
Receptors, Estrogen | 2 | 2005 | 384 | 0.440 |
Why?
|
Alu Elements | 1 | 2012 | 15 | 0.420 |
Why?
|
Acetamides | 2 | 2015 | 26 | 0.420 |
Why?
|
Women's Health | 2 | 2023 | 100 | 0.410 |
Why?
|
Genes, Tumor Suppressor | 1 | 2011 | 157 | 0.390 |
Why?
|
Poisson Distribution | 7 | 2018 | 51 | 0.380 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2012 | 96 | 0.370 |
Why?
|
Young Adult | 7 | 2024 | 5974 | 0.370 |
Why?
|
Incidence | 10 | 2021 | 1576 | 0.370 |
Why?
|
Colorectal Neoplasms | 1 | 2017 | 938 | 0.360 |
Why?
|
Atrazine | 2 | 2011 | 2 | 0.360 |
Why?
|
Surveys and Questionnaires | 10 | 2022 | 2501 | 0.350 |
Why?
|
Risk Assessment | 8 | 2023 | 2261 | 0.350 |
Why?
|
Military Medicine | 1 | 2009 | 20 | 0.350 |
Why?
|
Longevity | 1 | 2009 | 51 | 0.350 |
Why?
|
Odds Ratio | 7 | 2012 | 678 | 0.340 |
Why?
|
Permethrin | 1 | 2008 | 9 | 0.340 |
Why?
|
United States | 9 | 2024 | 6665 | 0.340 |
Why?
|
Organic Chemicals | 1 | 2008 | 33 | 0.330 |
Why?
|
Logistic Models | 4 | 2020 | 1185 | 0.310 |
Why?
|
Lung Neoplasms | 4 | 2017 | 2261 | 0.310 |
Why?
|
Topography, Medical | 1 | 2006 | 4 | 0.280 |
Why?
|
Agriculture | 5 | 2010 | 38 | 0.280 |
Why?
|
Aged | 17 | 2019 | 18402 | 0.270 |
Why?
|
Adipose Tissue | 2 | 2005 | 240 | 0.270 |
Why?
|
Age Factors | 5 | 2021 | 1849 | 0.270 |
Why?
|
Pesticide Residues | 1 | 2005 | 2 | 0.270 |
Why?
|
Risk | 2 | 2021 | 674 | 0.260 |
Why?
|
Sequence Analysis, DNA | 3 | 2012 | 853 | 0.240 |
Why?
|
Meningeal Neoplasms | 1 | 2024 | 61 | 0.230 |
Why?
|
Meningioma | 1 | 2024 | 60 | 0.230 |
Why?
|
Cadherins | 2 | 2016 | 151 | 0.230 |
Why?
|
Registries | 5 | 2019 | 702 | 0.230 |
Why?
|
General Practitioners | 1 | 2023 | 12 | 0.230 |
Why?
|
Veterans | 1 | 2024 | 72 | 0.230 |
Why?
|
Drama | 1 | 2022 | 7 | 0.220 |
Why?
|
Antigens, CD | 2 | 2016 | 458 | 0.220 |
Why?
|
Risk Factors | 8 | 2023 | 5416 | 0.210 |
Why?
|
Primary Prevention | 1 | 2023 | 85 | 0.210 |
Why?
|
American Cancer Society | 1 | 2021 | 13 | 0.210 |
Why?
|
Confidence Intervals | 5 | 2011 | 229 | 0.210 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2021 | 27 | 0.210 |
Why?
|
Intimate Partner Violence | 1 | 2021 | 20 | 0.210 |
Why?
|
Glioblastoma | 1 | 2024 | 255 | 0.200 |
Why?
|
Core Binding Factor Alpha 3 Subunit | 2 | 2011 | 4 | 0.200 |
Why?
|
Patient Care | 1 | 2022 | 100 | 0.200 |
Why?
|
Papillomavirus Vaccines | 1 | 2021 | 58 | 0.200 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2011 | 104 | 0.190 |
Why?
|
Follow-Up Studies | 4 | 2021 | 3636 | 0.190 |
Why?
|
Alabama | 1 | 2019 | 13 | 0.180 |
Why?
|
Blast Injuries | 1 | 2020 | 11 | 0.180 |
Why?
|
Age Distribution | 2 | 2018 | 204 | 0.180 |
Why?
|
Sexual Behavior | 1 | 2022 | 302 | 0.180 |
Why?
|
Guideline Adherence | 1 | 2021 | 223 | 0.180 |
Why?
|
Contraception | 1 | 2020 | 88 | 0.180 |
Why?
|
Communication | 1 | 2023 | 440 | 0.180 |
Why?
|
Inhalation Exposure | 1 | 2019 | 28 | 0.180 |
Why?
|
Personal Protective Equipment | 1 | 2019 | 32 | 0.180 |
Why?
|
Counseling | 1 | 2020 | 145 | 0.170 |
Why?
|
Headache | 1 | 2019 | 73 | 0.170 |
Why?
|
Baltimore | 2 | 2017 | 36 | 0.170 |
Why?
|
Fungicides, Industrial | 2 | 2008 | 2 | 0.170 |
Why?
|
Primary Health Care | 1 | 2022 | 339 | 0.170 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2011 | 381 | 0.170 |
Why?
|
Pennsylvania | 1 | 2018 | 75 | 0.160 |
Why?
|
Chi-Square Distribution | 1 | 2018 | 364 | 0.160 |
Why?
|
Brain Injuries, Traumatic | 1 | 2020 | 86 | 0.160 |
Why?
|
Syndrome | 1 | 2018 | 446 | 0.160 |
Why?
|
Self Report | 1 | 2019 | 288 | 0.160 |
Why?
|
Physician-Patient Relations | 1 | 2023 | 610 | 0.160 |
Why?
|
Universities | 1 | 2018 | 135 | 0.150 |
Why?
|
Epigenesis, Genetic | 2 | 2012 | 479 | 0.150 |
Why?
|
Intestinal Obstruction | 1 | 2017 | 88 | 0.150 |
Why?
|
Glutathione S-Transferase pi | 1 | 2016 | 18 | 0.150 |
Why?
|
DNA Modification Methylases | 1 | 2016 | 25 | 0.150 |
Why?
|
DNA Repair Enzymes | 1 | 2016 | 52 | 0.140 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 860 | 0.140 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 857 | 0.140 |
Why?
|
Environmental Monitoring | 2 | 2021 | 71 | 0.140 |
Why?
|
Chlorpyrifos | 2 | 2007 | 4 | 0.140 |
Why?
|
Retrospective Studies | 4 | 2019 | 8475 | 0.140 |
Why?
|
Cytokines | 1 | 2020 | 776 | 0.140 |
Why?
|
Academic Medical Centers | 1 | 2018 | 379 | 0.130 |
Why?
|
Thyroid Hormones | 1 | 2018 | 321 | 0.130 |
Why?
|
Carcinogens, Environmental | 1 | 2015 | 5 | 0.130 |
Why?
|
International Agencies | 1 | 2015 | 34 | 0.130 |
Why?
|
Publications | 1 | 2015 | 26 | 0.130 |
Why?
|
Tumor Suppressor Proteins | 1 | 2016 | 279 | 0.130 |
Why?
|
Sunburn | 1 | 2014 | 8 | 0.130 |
Why?
|
Louisiana | 1 | 2014 | 17 | 0.130 |
Why?
|
Colonic Neoplasms | 3 | 2009 | 556 | 0.130 |
Why?
|
Heat Stress Disorders | 1 | 2014 | 11 | 0.130 |
Why?
|
Disaster Planning | 1 | 2014 | 24 | 0.120 |
Why?
|
Exanthema | 1 | 2014 | 36 | 0.120 |
Why?
|
Time Factors | 2 | 2021 | 5209 | 0.120 |
Why?
|
Fungi | 1 | 2014 | 65 | 0.120 |
Why?
|
Adolescent | 2 | 2024 | 8979 | 0.120 |
Why?
|
Sleep Deprivation | 1 | 2014 | 137 | 0.110 |
Why?
|
Decision Making | 1 | 2018 | 642 | 0.110 |
Why?
|
Neoplasm Staging | 1 | 2017 | 1937 | 0.110 |
Why?
|
Oman | 1 | 2011 | 5 | 0.100 |
Why?
|
Arabs | 1 | 2011 | 17 | 0.100 |
Why?
|
Cdh1 Proteins | 1 | 2010 | 1 | 0.100 |
Why?
|
Biomarkers | 1 | 2017 | 1718 | 0.100 |
Why?
|
Sulfites | 1 | 2010 | 26 | 0.100 |
Why?
|
SEER Program | 2 | 2009 | 184 | 0.090 |
Why?
|
Leukocytes | 1 | 2011 | 202 | 0.090 |
Why?
|
Cardia | 1 | 2009 | 5 | 0.090 |
Why?
|
Nicotinic Acids | 1 | 2009 | 8 | 0.090 |
Why?
|
Air Pollutants | 1 | 2010 | 78 | 0.090 |
Why?
|
Child | 1 | 2020 | 6926 | 0.090 |
Why?
|
Polymerase Chain Reaction | 1 | 2011 | 927 | 0.090 |
Why?
|
Life Style | 2 | 2008 | 189 | 0.080 |
Why?
|
Greenland | 1 | 2008 | 6 | 0.080 |
Why?
|
Captan | 1 | 2008 | 1 | 0.080 |
Why?
|
Aged, 80 and over | 4 | 2007 | 6501 | 0.080 |
Why?
|
Cause of Death | 1 | 2009 | 277 | 0.080 |
Why?
|
Nitriles | 1 | 2008 | 149 | 0.080 |
Why?
|
Cell Cycle Proteins | 1 | 2010 | 388 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2011 | 532 | 0.080 |
Why?
|
Connecticut | 2 | 2004 | 27 | 0.080 |
Why?
|
Nitrates | 1 | 2007 | 35 | 0.080 |
Why?
|
Water Supply | 1 | 2007 | 60 | 0.080 |
Why?
|
Health Status | 1 | 2009 | 360 | 0.070 |
Why?
|
Dicamba | 1 | 2006 | 1 | 0.070 |
Why?
|
Brain | 1 | 2017 | 2216 | 0.070 |
Why?
|
Montana | 1 | 2006 | 8 | 0.070 |
Why?
|
North Dakota | 1 | 2006 | 10 | 0.070 |
Why?
|
South Dakota | 1 | 2006 | 47 | 0.070 |
Why?
|
Minnesota | 1 | 2006 | 46 | 0.070 |
Why?
|
Disease Progression | 1 | 2010 | 1531 | 0.070 |
Why?
|
Aniline Compounds | 1 | 2006 | 55 | 0.070 |
Why?
|
Triazines | 1 | 2006 | 53 | 0.070 |
Why?
|
Hematologic Neoplasms | 2 | 2006 | 329 | 0.070 |
Why?
|
Carcinoma | 1 | 2009 | 436 | 0.070 |
Why?
|
Chromatography, Gas | 1 | 2005 | 28 | 0.070 |
Why?
|
Buttocks | 1 | 2005 | 10 | 0.070 |
Why?
|
Parity | 1 | 2005 | 93 | 0.070 |
Why?
|
Menopause | 1 | 2005 | 71 | 0.070 |
Why?
|
Cytochrome P-450 CYP1A1 | 1 | 2004 | 7 | 0.070 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2009 | 382 | 0.060 |
Why?
|
India | 1 | 2005 | 120 | 0.060 |
Why?
|
Glycine | 1 | 2005 | 90 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 1 | 2017 | 3352 | 0.060 |
Why?
|
Statistics as Topic | 1 | 2005 | 238 | 0.060 |
Why?
|
Mouth Neoplasms | 1 | 2006 | 194 | 0.060 |
Why?
|
Research Design | 2 | 2004 | 594 | 0.060 |
Why?
|
Pancreatic Neoplasms | 1 | 2009 | 645 | 0.060 |
Why?
|
Breast | 1 | 2005 | 286 | 0.060 |
Why?
|
Carcinoma, Renal Cell | 1 | 2007 | 426 | 0.060 |
Why?
|
Prognosis | 1 | 2010 | 3674 | 0.060 |
Why?
|
Certification | 1 | 2023 | 58 | 0.060 |
Why?
|
Models, Theoretical | 1 | 2005 | 482 | 0.050 |
Why?
|
Immunity, Humoral | 1 | 2023 | 67 | 0.050 |
Why?
|
Pilot Projects | 1 | 2005 | 839 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2007 | 621 | 0.050 |
Why?
|
Turtles | 1 | 2021 | 14 | 0.050 |
Why?
|
Antibodies, Viral | 1 | 2023 | 293 | 0.050 |
Why?
|
Multiple Organ Failure | 1 | 2021 | 53 | 0.050 |
Why?
|
Immunohistochemistry | 1 | 2005 | 1753 | 0.050 |
Why?
|
Vaccination | 1 | 2023 | 254 | 0.050 |
Why?
|
Multiple Myeloma | 1 | 2005 | 307 | 0.050 |
Why?
|
Vertebrates | 1 | 2021 | 90 | 0.050 |
Why?
|
Immunoglobulin G | 1 | 2023 | 456 | 0.050 |
Why?
|
Polymorphism, Genetic | 1 | 2004 | 819 | 0.050 |
Why?
|
Empathy | 1 | 2022 | 147 | 0.050 |
Why?
|
Fishes | 1 | 2021 | 137 | 0.050 |
Why?
|
Birds | 1 | 2021 | 157 | 0.050 |
Why?
|
Pregnancy | 1 | 2005 | 2893 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2020 | 1019 | 0.040 |
Why?
|
Biomarkers, Tumor | 1 | 2004 | 1464 | 0.030 |
Why?
|
Inflammation | 1 | 2020 | 920 | 0.030 |
Why?
|
Public Health | 1 | 2015 | 129 | 0.030 |
Why?
|
Sampling Studies | 1 | 2010 | 70 | 0.020 |
Why?
|
Biomedical Research | 1 | 2015 | 375 | 0.020 |
Why?
|
Nervous System Neoplasms | 1 | 2010 | 11 | 0.020 |
Why?
|
Organothiophosphorus Compounds | 1 | 2010 | 17 | 0.020 |
Why?
|
Organophosphorus Compounds | 1 | 2010 | 55 | 0.020 |
Why?
|
Patients | 1 | 2010 | 100 | 0.020 |
Why?
|
Data Collection | 1 | 2010 | 372 | 0.020 |
Why?
|
Nitroso Compounds | 1 | 2007 | 12 | 0.020 |
Why?
|
Amines | 1 | 2007 | 27 | 0.020 |
Why?
|
Leukemia | 1 | 2010 | 320 | 0.020 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2010 | 261 | 0.020 |
Why?
|
Food Contamination | 1 | 2007 | 31 | 0.020 |
Why?
|
Employment | 1 | 2007 | 52 | 0.020 |
Why?
|
Causality | 1 | 2007 | 81 | 0.020 |
Why?
|
Sex Distribution | 1 | 2007 | 173 | 0.020 |
Why?
|
Poland | 1 | 2007 | 17 | 0.020 |
Why?
|
Epidemiologic Studies | 1 | 2007 | 17 | 0.020 |
Why?
|
Electromagnetic Fields | 1 | 2007 | 26 | 0.020 |
Why?
|
Sex Factors | 1 | 2009 | 1054 | 0.020 |
Why?
|
Water | 1 | 2007 | 275 | 0.020 |
Why?
|
Accidents, Occupational | 1 | 2005 | 8 | 0.020 |
Why?
|
Spouses | 1 | 2005 | 33 | 0.020 |
Why?
|
Lymphoma | 1 | 2006 | 262 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2007 | 567 | 0.020 |
Why?
|
Prevalence | 1 | 2008 | 1239 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2005 | 319 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 2005 | 231 | 0.010 |
Why?
|
Animals | 1 | 2021 | 26581 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2007 | 827 | 0.010 |
Why?
|